TY  - JOUR 
T1  - Systematic review of the efficacy and safety of lenvatinib vs. sorafenib as first-line treatments for hepatocellular carcinoma
JO  - Clinics
A1  - Bo, Wentao
A1  - Wang, Zhenguo
A1  - Dong, Xiuhua
A1  - Zou, Jing
SN  - 1807-5932
UL  - 10.1016/j.clinsp.2026.100869
VL  - 81 
Y1  - 2026
PB  - Brasil 
ER  -